Reviews
Systematic reviews
Search a topic, title, author or review id. The Findings tab shows what the reviews found for the same words, grouped by question; the Studies tab shows the primary studies they include.
62 reviews, newest first
Inhaled bronchodilators for the prevention and treatment of chronic lung disease in preterm infants
Cochraneheadline outcomes only
4 findings
Inhaled corticosteroids versus placebo for stable chronic obstructive pulmonary disease
Cochraneheadline outcomes only
6 findings
Inhaled corticosteroids with combination inhaled long‐acting beta2‐agonists and long‐acting muscarinic antagonists for chronic obstructive pulmonary disease
Cochraneheadline outcomes only
9 findings
Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease
Cochraneheadline outcomes only
7 findings
Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis
Cochraneheadline outcomes only
10 findings
Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis
Cochraneheadline outcomes only
12 findings
Addition of long‐acting beta2 agonists or long‐acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta‐analysis
Cochraneheadline outcomes only
43 findings
Inhaled anti‐pseudomonal antibiotics for long‐term therapy in cystic fibrosis
Cochraneheadline outcomes only
56 findings
Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants
Cochraneheadline outcomes only
4 findings
Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children
Cochraneheadline outcomes only
8 findings
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis
Cochraneheadline outcomes only
14 findings
Inhaled nitric oxide for treating pain crises in people with sickle cell disease
Cochraneheadline outcomes only
4 findings
Short‐acting inhaled bronchodilators for cystic fibrosis
Cochraneheadline outcomes only
21 findings
Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and varying doses of inhaled corticosteroids in adolescents and adults with asthma: a systematic review and network meta‐analysis
Cochraneheadline outcomes only
161 findings
Inhaled corticosteroids for the treatment of COVID‐19
Cochraneheadline outcomes only
7 findings
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events
Cochraneheadline outcomes only
18 findings
Inhaled mannitol for cystic fibrosis
Cochraneheadline outcomes only
30 findings
Inhaled corticosteroids for cystic fibrosis
Cochraneheadline outcomes only
7 findings
Inhaled steroids with and without regular formoterol for asthma: serious adverse events
Cochraneheadline outcomes only
8 findings
Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth
Cochraneheadline outcomes only
5 findings
Inhaled corticosteroids for bronchiectasis
Cochraneheadline outcomes only
10 findings
Inhaled steroids with and without regular salmeterol for asthma: serious adverse events
Cochraneheadline outcomes only
10 findings
Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic antagonists for people with chronic obstructive pulmonary disease
Cochraneheadline outcomes only
7 findings
Inhaled nitric oxide for respiratory failure in preterm infants
Cochraneheadline outcomes only
11 findings
Combined inhaled beta‐agonist and anticholinergic agents for emergency management in adults with asthma
Cochraneheadline outcomes only
7 findings